礼来公司的三重激动剂瑞他曲肽显著改善了体重、糖化血红蛋白A1C、膝骨关节炎疼痛和阻塞性睡眠呼吸暂停，展现了其在治疗肥胖及其并发症方面的卓越潜力。
印第安纳波利斯，2026年6月6日/PRNewswire/ -- Zepbound（替泽帕肽）和Foundayo（奥福格列酮）的生产商礼来公司（纽约证券交易所代码：LLY）今日宣布，其新药retatrutide的关键性3期临床试验取得了更多积极结果……
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
الاسئلة الشائعة
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
